OBJECTIVE. The purpose of this study was to determine whether MR imaging features can reliably distinguish hemangiomas from malignant soft-tissue masses.
emangiomas are common neoplasms that account for 7% of all benign soft-tissue tumors [1] . Although the biologic classification of vascular anomalies proposed by Mulliken and Glowacki [2] separates hemangioma of infancy from vascular malformations, the term "hemangioma" is used in this article to generically encompass hemangiomas and vascular malformations.
Most patients with deep-seated hemangiomas present with either pain or intermittent swelling. Patients occasionally describe a poorly delineated mass that becomes larger or smaller from time to time. Deep-seated hemangiomas cannot be distinguished from malignant soft-tissue tumors without imaging studies. When imaging can distinguish hemangiomas from malignant soft-tissue tumors, patient management is affected regarding the need for further imaging or biopsy and the choice of therapy.
Other researchers have described the MR imaging features of hemangiomas [1, [3] [4] [5] . Some studies have indicated that hemangiomas may be correctly diagnosed and distinguished from malignant soft-tissue masses by their characteristic MR appearances [6] [7] [8] . Our objective in this study was to compare the MR imaging features of hemangiomas with those of malignant soft-tissue masses and to determine the combination of features that would allow hemangiomas to be distinguished from malignant soft-tissue masses.
Materials and Methods
The MR images of 22 patients with peripheral hemangiomas and 22 patients with primary malignant soft-tissue masses were retrospectively reviewed. The patients were consecutively imaged at our institution between 1992 and 1997 for hemangiomas and between 1995 and 1997 for the malignant soft-tissue masses. All patients were imaged before biopsy or surgery, when performed.
The age range of the patients with hemangiomas was 2-43 years (median, 12 years) and with malignant soft-tissue masses was 3 months to 87 years (median, 53 years). Of the 22 hemangiomas, the diagnosis (three arterial venous malformations, two venous malformations, one benign vascular mal-
Teo et al.
formation, one cavernous hemangioma, three hemangiomas) was made histologically in 10 patients, on angiography in six, and by the characteristic clinical findings and follow-up in the remaining six patients. Malignant soft-tissue masses were confirmed histologically in all 22 patients. The soft-tissue masses were seven malignant fibrous histiocytomas, five rhabdomyosarcomas, two neurofibrosarcomas, two primitive neuroectodermal tumors, and six other soft-tissue sarcomas.
All patients were imaged using a Signa 1.5-T scanner (General Electric Medical Systems, Milwaukee, WI). T1-and T2-weighted images were acquired in all patients. Eleven hemangiomas and 21 malignant soft-tissue masses were imaged after IV gadolinium administration (gadopentetate dimeglumine, 0.1 mmol/kg) using T1-weighted images with fat saturation. Gadolinium-enhanced images were obtained with a short delay after administration.
The images were interpreted without knowledge of the final diagnosis of the soft-tissue mass or patient age. Two radiologists reviewed the images and arrived at a consensus interpretation of the imaging features. A third radiologist reviewed the images independently after being educated with regard to the imaging definitions. The purpose of the third reader was to provide a reliability measure for the imaging criteria used. The masses were evaluated for the signal intensity of the lesions on unenhanced T1-weighted images, gadolinium-enhanced T1-weighted images, and T2-weighted images and for the morphologic features of the lesions: lobulation, septation, and the presence of central low-signal-intensity dots on T2-weighted images. Signal intensity was characterized as isointense or mildly, moderately, or markedly hyperintense compared with the signal intensity of skeletal muscle. A lesion was considered lobulated if it showed internal septations resulting in a grapelike configuration ( Figs. 1 and 2 ). It was considered septate if internal divisions or septa subdivided it into several smaller compartments (Fig.  3) . The central low-signal-intensity dot sign on T2-weighted images was deemed to be present if at least three or more punctate central low-signal-intensity dots were present in the center of the lobulation (Fig. 2) .
To obtain objective evaluation of the signal intensities of the lesions, measurements of regions of interest of representative portions of the lesions were compared with similar sized regions of interest in adjacent skeletal muscle. A ratio between the two signal intensities was calculated for each lesion seen on both gadolinium-enhanced T1-weighted images and unenhanced T2-weighted images. The T2 relaxation time of the lesions was calculated for 18 hemangiomas and eight malignant soft-tissue masses in which dual-echo imaging was performed. T2 was calculated using the formula: T2 = (TE 2 -TE 1 ) / (Ln [ROI 1 / ROI 2 ]), where TE 1 = time to first echo (msec), TE 2 = time to second echo (msec), Ln = natural logarithm, ROI 1 = signal intensity of region of interest on first echo, and ROI 2 = signal of intensity of region of interest on second echo.
Statistical analysis was performed using the chi-square test for categoric data and the independent t test for continuous data. The agreement between the consensus and the independent readings was assessed using the kappa statistic. Statistical significance was set at the 0.05 level.
Results

Characteristics on T1-Weighted Images
T1-weighted images showed no reliable distinguishing features. Both hemangiomas and soft-tissue tumors were low in signal intensity.
Characteristics on T2-Weighted Images
The frequency of lobulation, septation, and central low-intensity dots on T2-weighted images was much higher for hemangiomas than for malignant soft-tissue tumors (Table 1) . This difference was statistically significant for the consensus and independent readings. Masses with all three imaging characteristics (lobulations, septations, and central low-intensity dots) present were exclusively hemangiomas, independent of whether the consensus or independent readings were used ( Table 2) . Hemangiomas frequently had a lobulated appearance and central low-intensity dot. On the other hand, malignant soft-tissue tumors occasionally had septations and rarely had a central low-intensity dot.
The T2 signal intensities of hemangiomas were generally higher than those of malignant soft-tissue masses (Table 3) . Although subjective, this difference was found to be statistically significant for both the consensus and independent readings. Although the quantitative analysis revealed higher values of signal intensity ratios for hemangiomas than for malignant soft-tissue masses (Fig. 4) , no statistical significance was observed.
Characteristics on Gadolinium-Enhanced T1-Weighted Images
In general, hemangiomas were judged to enhance markedly compared with malignant soft-tissue tumors (Table 4) . This difference was statistically significant for both the consensus and independent readings. Although the median of the signal-intensity ratios for hemangiomas was higher than the median for malignant soft-tissue masses (Fig. 5) , the difference was not statistically significant.
Calculated T2 Relaxation Times
In general, hemangiomas had a higher T2 relaxation time than malignant soft-tissue masses (Fig. 6) ; however, the difference in calculated T2 relaxation times between hemangiomas and malignant soft-tissue masses was not statistically significant.
Consensus Versus Independent Readings
Substantial agreement occurred between the two readings for the assessment of lobulations and central-low intensity dots ( κ = 0.62-0.68), moderate agreement for the signal characteristic on T2-weighted images and the degree of enhancement after gadolinium ( κ = 0.5-0.53), and fair agreement for the assessment of septation ( κ = 0.3).
Discusson
This study shows that hemangiomas have characteristic MR imaging features that enable their differentiation from malignant soft-tissue masses without the need for biopsy. Specifically, these features are the lobulated and septate appearance of hemangiomas compared with malignant soft-tissue masses; the central low-intensity dot sign on T2-weighted imaging characteristically seen in hemangiomas; marked enhancement of hemangiomas after gadolinium administration on T1-weighted imaging; and the high T2 signal of hemangiomas compared with that of malignant soft-tissue masses. It is the summation of all these features, rather than any one particular feature taken in isolation, that will help the radiologist make a diagnosis of hemangioma.
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sions may as a group manifest MR imaging characteristics that distinguish them from malignant soft-tissue masses. Admittedly, the grouping of a continuum of lesions blurs their distinction; however, it highlights the importance of distinguishing benign from malignant soft-tissue masses. In this paper, we have therefore used the generic term "hemangioma" to encompass all hemangiomatous lesions and vascular malformations, although pathologic and imaging distinctions exist [2, 9] . Histologically, hemangiomas are vascular lesions containing nonvascular elements such as fat, fibrous and myxoid tissue, smooth muscle, thrombus, and even bone [10] . The MR imaging appearance of deep peripheral hemangiomas has been well described in the literature [1, 3-5, 11, 12] .
Characteristics on T2-Weighted Imaging
On T2-weighted images, hemangiomas have been described as having a multilobulated high-signal-intensity configuration interspersed with linear and lacelike areas of low or intermediate signal intensity [1, 3, 4, 12] . This morphologic appearance is supported by our study. These findings were also shown by Cohen et al. [13] , who suggested that the distinctive septate-lobulated appearance on T2-weighted imaging correlated with fibrous and fatty septa (low signal) between endothelial-lined vascular channels (high signal) identified on histologic examination. Our study suggests that the T2 signal intensity of hemangiomas is greater than that of malignant soft-tissue masses, although the quantitative assessment was not shown to be statistically significant. The lack of statistical significance was probably caused by the small sample in which this quantitative analysis was performed. The T2 signal intensity of lesions is a reflection of their T2 relaxation times. Hemangiomas have high T2 values, which may reflect pooling of the blood within cavernous spaces and slow flow within dilated venous channels [5] . Buetow et al. [3] suggested that the high T2 signal intensity of hemangiomas appeared to be related to increased free water in stagnant blood pooled in the larger vessels of lesions. The calculated T2 was not significantly different between hemangiomas and malignant soft-tissue masses in our study. However, the small numbers of malignant soft-tissue masses for which the T2 value could be calculated may have contributed to the lack of statistical significance. The central low-intensity dot sign on T2-weighted imaging in hemangiomas has been previously described [1] . Our study has shown that this sign is highly specific for hemangiomas compared with malignant soft-tissue masses. These rounded foci of low signal intensity seen in hemangiomas may represent fibrofatty septa seen in cross section, or hyalinized or thrombosed vascular channels [4] . Hawnaur et al. [11] have also suggested that smooth muscle components, fast flow within blood vessels, calcification, or ossification may give rise to this appearance. The central low-intensity dots are not likely to represent phleboliths because they were not recognizable on the T1-weighted images or on conventional radiographs. Fast flow in blood vessels is a likely cause in some cases because the central low-intensity dots disappear after gadolinium administration (Fig.  2C ). This central low-intensity dot has also been described in benign neurofibromas, where it produces a so-called targetlike appearance [14, 15] . The pattern of enhancement is helpful in distinguishing between neurofibromas and hemangiomas. Because the central low-intensity dot in benign neurofibromas is caused by dense collagen, it is not likely to exhibit enhancement with gadolinium as hemangiomas do [15] .
Characteristics on T1-Weighted Gadolinium-Enhanced Images
Qualitative assessment revealed that hemangiomas showed a greater degree of enhancement with gadolinium than did malignant soft-tissue masses. Quantitative assessment of enhancement with gadolinium showed that the median of the region-of-interest ratios of hemangiomas was greater than that of malignant soft-tissue masses; however, the difference was not statistically significant. The small sample of hemangiomas in which gadolinium had been given may have contributed to the lack of statistical significance. Intense enhancement, therefore, is supportive of the diagnosis of hemangioma but should be used in corroboration of other findings to reach the diagnosis.
We did not specifically analyze whether the presence of fat or its distribution in the lesion was a feature distinguishing hemangiomas from malignant soft-tissue masses. Fatcontaining malignant soft-tissue masses are rare in children. Although intercalated fat is a feature of hemangiomas, other fat-containing soft-tissue masses, most notably lipoblastoma, do occur in children [16, 17] .
A possible limitation of this study is the small number of patients in both lesion groups in whom the quantitative parameters could be evaluated. This may have contributed to the lack of statistical significance in the differences in the T2 signal intensities, T2 relaxation times, and lesion enhancement with gadolinium in the objective parts of the study.
A second limitation was the difference in the age ranges of the two patient populations. The group of patients with hemangiomas had an age range that was substantially lower than the age range of patients with malignant softtissue masses. The difference in age in our study between the two patient populations was necessitated by the relatively small number of malignant soft-tissue masses imaged with MR in pediatric patients. The difference in age range is not thought to be critical because the morphology of malignant soft-tissue masses on MR imaging is unlikely to be affected by the age of patients. The age of the patient in itself should not be overlooked as valuable information in helping to distinguish hemangiomas from malignant soft-tissue masses. Other clinical factors, such as chronicity of the mass and a rapid increase in its size, are also helpful.
A third limitation of this study is the subjective assessment of imaging features such as septation, lobulation, and the degree of enhancement after gadolinium administration. Different observers may develop different thresholds, which is reflected by some degree of discrepancy in the assessment of septations and lesion enhancement between the consensus reading and the independent reader in our study. However, despite this variability and regardless of whether the consensus or independent readings are used, the combination of imaging findings (lobulation, septation, and central low-intensity dot) has predictive value.
Last, this investigation is limited by the relatively small number of patients studied. It was not possible to include all types of malignant soft-tissue tumors in this analysis. Boon et al. [18] reported two cases of congenital fibrosarcoma mimicking congenital hemangioma. No case of this tumor was included in our study. Although it is possible that application of our criteria allowed the 
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correct diagnosis, further analysis of a larger number of patients with a wider spectrum of malignant soft-tissue masses is warranted.
In summary, this study suggests that hemangiomas can be distinguished from malignant soft-tissue masses on MR imaging by using a combination of morphologic features, the degree of enhancement after the administration of gadolinium, and the T2 signal intensity, potentially obviating biopsy in many cases.
